Wall Street analysts expect Oak Street Health, Inc. (NYSE:OSH) to post earnings per share (EPS) of ($0.22) for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Oak Street Health’s earnings. The lowest EPS estimate is ($0.32) and the highest is ($0.14). The company is scheduled to announce its next quarterly earnings results on Tuesday, June 8th.
According to Zacks, analysts expect that Oak Street Health will report full-year earnings of ($1.19) per share for the current fiscal year, with EPS estimates ranging from ($1.72) to ($0.84). For the next fiscal year, analysts anticipate that the firm will report earnings of ($0.72) per share, with EPS estimates ranging from ($1.31) to ($0.38). Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Oak Street Health.
Oak Street Health (NYSE:OSH) last posted its earnings results on Monday, March 8th. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.15). The company had revenue of $248.70 million for the quarter, compared to analyst estimates of $231.79 million. The business’s quarterly revenue was up 43.3% compared to the same quarter last year.
OSH has been the topic of several recent research reports. Truist lifted their target price on shares of Oak Street Health from $60.00 to $72.00 in a research report on Friday, December 18th. Morgan Stanley boosted their price target on shares of Oak Street Health from $73.00 to $79.00 and gave the stock an “overweight” rating in a research report on Thursday, March 18th. Wolfe Research assumed coverage on shares of Oak Street Health in a research report on Thursday, January 28th. They issued an “outperform” rating and a $62.00 price target on the stock. Canaccord Genuity assumed coverage on shares of Oak Street Health in a research report on Tuesday, March 2nd. They issued a “buy” rating and a $67.00 price target on the stock. Finally, Zacks Investment Research downgraded shares of Oak Street Health from a “hold” rating to a “sell” rating in a research report on Saturday, February 20th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and twelve have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $66.92.
NYSE:OSH traded up $2.51 during mid-day trading on Friday, hitting $62.40. 17,183 shares of the company’s stock were exchanged, compared to its average volume of 1,301,177. The company has a 50 day simple moving average of $55.80 and a 200-day simple moving average of $53.96. Oak Street Health has a fifty-two week low of $37.11 and a fifty-two week high of $66.31.
In other Oak Street Health news, insider Robert Guenthner sold 5,902 shares of the business’s stock in a transaction on Thursday, March 11th. The shares were sold at an average price of $55.34, for a total transaction of $326,616.68. Following the completion of the sale, the insider now owns 557,148 shares in the company, valued at approximately $30,832,570.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director General Atlantic Llc sold 7,429,453 shares of the business’s stock in a transaction on Tuesday, February 16th. The shares were sold at an average price of $54.18, for a total transaction of $402,527,763.54. The disclosure for this sale can be found here. Insiders sold a total of 7,453,061 shares of company stock valued at $403,833,758 in the last quarter. 5.66% of the stock is currently owned by company insiders.
Hedge funds have recently made changes to their positions in the business. Principal Financial Group Inc. bought a new stake in Oak Street Health during the 3rd quarter valued at $1,155,000. Peregrine Capital Management LLC increased its stake in Oak Street Health by 5.1% during the 4th quarter. Peregrine Capital Management LLC now owns 284,206 shares of the company’s stock valued at $17,382,000 after purchasing an additional 13,854 shares in the last quarter. Rhumbline Advisers increased its stake in Oak Street Health by 54.2% during the 4th quarter. Rhumbline Advisers now owns 17,116 shares of the company’s stock valued at $1,047,000 after purchasing an additional 6,013 shares in the last quarter. Zweig DiMenna Associates LLC increased its stake in Oak Street Health by 56.5% during the 4th quarter. Zweig DiMenna Associates LLC now owns 138,500 shares of the company’s stock valued at $8,471,000 after purchasing an additional 50,000 shares in the last quarter. Finally, CWM LLC bought a new stake in Oak Street Health during the 4th quarter valued at $1,259,000. Institutional investors and hedge funds own 66.59% of the company’s stock.
Oak Street Health Company Profile
Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.